Paper908034
Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler IJ and 1 other. Cancer Res, 1977. Cited by 92 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Papers, record 908034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/908034
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Lymphocytes | Major topic |
| Melanoma | Major topic |
| Animals | |
| Cell Aggregation | |
| Cells, Cultured | |
| Cross Reactions | |
| Histocompatibility Antigens | |
| In Vitro Techniques | |
| Macrophages | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Neoplasms, Experimental |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37673917 | Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy. | Nat Commun | 2023 | https://conductscience.org/library/papers/37673917 | PubMed |
| 29399407 | Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/29399407 | PubMed |
| 25640991 | Mouse model for pre-clinical study of human cancer immunotherapy. | Curr Protoc Immunol | 2015 | https://conductscience.org/library/papers/25640991 | PubMed |
| 18432774 | B16 as a mouse model for human melanoma. | Curr Protoc Immunol | 2001 | https://conductscience.org/library/papers/18432774 | PubMed |
| 18214474 | TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/18214474 | PubMed |
| 12909737 | Experimental animal models of pancreatic carcinogenesis and metastasis. | Int J Gastrointest Cancer | 2003 | https://conductscience.org/library/papers/12909737 | PubMed |
| 11558630 | Mouse models of metastatic pancreatic adenocarcinoma. | Int J Pancreatol | 2001 | https://conductscience.org/library/papers/11558630 | PubMed |
| 8674280 | Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs. | Clin Exp Metastasis | 1996 | https://conductscience.org/library/papers/8674280 | PubMed |
| 7754628 | Biology of human colon cancer metastasis. | World J Surg | 1995 | https://conductscience.org/library/papers/7754628 | PubMed |
| 6965227 | Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6965227 | PubMed |
| 6616441 | The selective nature of metastasis. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6616441 | PubMed |
| 6352013 | Organ specific metastasis with special reference to avian systems. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6352013 | PubMed |
| 6231096 | Immunology of metastasis. Can the immune response cope with disseminated tumor? | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6231096 | PubMed |
| 3829045 | Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3829045 | PubMed |
| 3730254 | Radiation response of proliferating and quiescent subpopulations isolated from multicellular spheroids. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3730254 | PubMed |
| 3350842 | Mechanism of liver-specific metastatic tumor spread in a murine tumor model. | J Cancer Res Clin Oncol | 1988 | https://conductscience.org/library/papers/3350842 | PubMed |
| 3319276 | Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. | Cancer Metastasis Rev | 1987 | https://conductscience.org/library/papers/3319276 | PubMed |
| 3129225 | Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis. | Clin Exp Metastasis | 1988 | https://conductscience.org/library/papers/3129225 | PubMed |
| 1380062 | Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. | J Exp Med | 1992 | https://conductscience.org/library/papers/1380062 | PubMed |
| 311336 | The mechanism of T-cell mediated cytotoxicity. VI. T-cell projections and their role in target cell killing. | Immunology | 1979 | https://conductscience.org/library/papers/311336 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/908034
GET https://conductscience.org/api/papers/v1/908034/authors